How is CM Yogi Adityanath Enhancing the Start-Up Ecosystem in UP?

Click to start listening
How is CM Yogi Adityanath Enhancing the Start-Up Ecosystem in UP?

Synopsis

Chief Minister Yogi Adityanath is on a mission to cultivate the start-up ecosystem in Uttar Pradesh, highlighting the achievements of local laboratories in advancing Ayurveda-based medicines. With a focus on global outreach and innovation, this initiative promises to reshape the landscape of herbal medicine in India and beyond.

Key Takeaways

  • CM Yogi Adityanath is dedicated to fostering a start-up ecosystem in Uttar Pradesh.
  • Four Lucknow-based laboratories are making significant advancements in Ayurveda-based drugs.
  • BGR-34 is a key drug that has the potential for diabetes reversal.
  • The conclave showcased the increasing global demand for herbal medicine.
  • Government support is pivotal for startups looking to enter global markets.

Lucknow, Sep 18 (NationPress) Chief Minister Yogi Adityanath has committed to fostering a robust start-up ecosystem in Uttar Pradesh. He lauded the significant advancements made by four government laboratories located in Lucknow that are extending their reach globally with Ayurveda-based medicines, as stated by an official on Thursday.

While engaging with representatives from research institutions, startups, Ayurveda specialists, and policymakers at the two-day CSIR Startup Conclave, CM Adityanath commended the efforts of four laboratories affiliated with the Council of Scientific and Industrial Research (CSIR) — the National Botanical Research Institute (NBRI), the Central Institute of Medicinal and Aromatic Plants (CIMAP), the Indian Institute of Toxicology Research (IITR), and the Central Drug Research Institute (CDRI).

Collectively, these institutes have introduced 13 significant herbal drugs targeting lifestyle and chronic ailments, including BGR-34 for diabetes, Paclitaxel derived from the bark of the Arjuna tree for blood cancer, and Picroliv for fatty liver and degeneration of liver cells.

BGR-34 captured the most attention at the conclave, as it is a formulation co-developed by NBRI and CIMAP using six herbs: Daruharidra, Giloy, Vijaysar, Gudmar, Manjistha, and Methi. While already acclaimed for managing blood sugar levels, this drug is being positioned as a viable option for long-term diabetes reversal, an area that is gaining focus in global healthcare.

“Globally, the conversation is shifting from diabetes management to diabetes reversal,” remarked Dr. Sanchit Sharma, who oversees the commercial marketing of BGR-34. “Formulations like BGR-34 exemplify the collaboration between Ayurveda and modern science, and such innovations could lay the groundwork for a diabetes-free future,” he added.

The conclave emphasized the increasing potential of India’s herbal medicine sector in both domestic and international markets for policymakers and industry leaders.

During his attendance at the conclave, Union Science and Technology Minister Dr. Jitendra Singh remarked that the initiative showcases the “lab to people” innovation model.

He encouraged startups to utilize technologies developed by the government and expand them into global markets, where the demand for natural and herbal solutions is on the rise. Uttar Pradesh Chief Minister Yogi Adityanath, who toured the exhibition alongside Dr. Singh, also urged researchers to expedite the commercialization of herbal products.

Point of View

I recognize the commitment of CM Yogi Adityanath towards building a vibrant start-up culture in Uttar Pradesh. This initiative not only highlights the importance of Ayurveda but also showcases India's potential on the global stage. With strong government support, the future of herbal medicine looks promising.
NationPress
20/09/2025

Frequently Asked Questions

What is the main focus of CM Yogi Adityanath's initiative?
CM Yogi Adityanath aims to enhance the start-up ecosystem in Uttar Pradesh by promoting Ayurveda-based drugs developed by local laboratories.
What are some notable herbal drugs developed in Lucknow?
Notable herbal drugs include BGR-34 for diabetes, Paclitaxel for blood cancer, and Picroliv for fatty liver.
What is BGR-34 and why is it significant?
BGR-34 is a herbal formulation that has gained attention for its potential in regulating blood sugar and possibly reversing diabetes.
How are the government laboratories contributing to healthcare?
These laboratories are developing drugs that address chronic diseases, thus contributing to both domestic health and global markets.
What did Union Minister Dr. Jitendra Singh say about innovation?
He highlighted the 'lab to people' model of innovation, encouraging startups to utilize government technologies for global outreach.